Boston Scientific Corporation (BSX): Among the Best Low Volatility Stocks to Invest In Now
We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against the other low volatility stocks.
What’s Behind the -1.33% Drop in Boston Scientific Corporation (BSX) Stock? Find Out Now!
On Thursday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $87.59 which represents a decrease of $-1.18 or -1.33% from the prior close of $88.77. The stock opened at $88.65 and touched a low of $87.
Needham Keeps Their Hold Rating on Boston Scientific (BSX)
Needham analyst Michael Matson maintained a Hold rating on Boston Scientific (BSX – Research Report) today. The company’s shares closed last
Boston Scientific’s Stock Surge
Spread the loveBoston Scientific, headquartered in Marlborough, has seen its stock surge by 50%, driven by a series of strategic acquisitions. Under CEO Mike Mahoney’s leadership, the company has completed over 40 acquisitions,
What’s Causing Boston Scientific Corporation (BSX) Stock’s 16.53% Jump Over the Last Six Months?
On Friday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $86.99 which represents a decrease of $-0.60 or -0.69% from the prior close of $87.59. The stock opened at $87.12 and touched a low of $86.
Boston Scientific (BSX) Gets a Buy from Truist Financial
In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Boston Scientific (BSX – Research Report). The
Zacks.com on MSN17h
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Boston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...
Orange County Business Journal1d
Boston Scientific Completes $3.7B Acquisition of Axonics
Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...
Boston Scientific’s WATCHMAN FLX: Poised for Growth with New Trial Results and Reimbursement Code
Mizuho Securities analyst Anthony Petrone has maintained their bullish stance on BSX stock, giving a Buy rating yesterday.Don't Miss our Black ...
health.economictimes.indiatimes20h
Boston Scientific launches multi-functional imaging system AVVIGO
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS ...
FierceBiotech14h
AHA 2024: Boston Scientific, Abbott tout long-term heart occluder data
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
Buy Rating on Boston Scientific: WATCHMAN Product’s Expanding Market Potential and Revenue Growth
In a report released on November 15, David Rescott from Robert W. Baird maintained a Buy rating on Boston Scientific (BSX – Research Report), ...
MarketWatch4d
Boston Scientific Corp. stock underperforms Friday when compared to competitors
Shares of Boston Scientific Corp. BSX shed 0.69% to $86.99 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 1.32% to ...
MassDevice1d
Boston Scientific Watchman FLX demonstrates superiority to anticoagulants in study
Boston Scientific announced positive three-year primary endpoint results from a clinical trial of its Watchman FLX device.
Pharmabiz18h
Boston Scientific WATCHMAN FLX LAAC device demonstrates superior bleeding risk reduction to OAC following a cardiac ablation in OPTION clinical trial
Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...